Developer docs
API playgroundTry for free, no card

Search company profiles

Haffkine Institute

Full company profile

uuid0031b2b

Namestring
Haffkine Institute
Websiteurl
haffkineinstitute.org
Company typeenum
Private
Founded yearint
1899
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersParel, India
HQ citystring
Parel
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biomedical research, vaccine production, infectious disease testing, microbiology research, biopharmaceuticals
Industry4 codes
1Microbiology & Infectious Disease Testing Laboratories
CodeHLAFAMADPrimaryYes
2Disease-Specific Reference Laboratory Networks (e.g., TB, HIV, Influenza)
CodeHLAJAIADPrimaryNo
3Schools of Medical Laboratory Science & Clinical Diagnostics
CodeEDAHAGAOPrimaryNo
4Microbiology & Infectious Disease Testing (Trial Support)
CodeHLAGAEAFPrimaryNo
NAICS code3 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code4 codes
  • Services-Medical Laboratories8071
  • Services-Testing Laboratories8734
  • Services-Commercial Physical & Biological Research8731
  • Biological Products, (No Disgnostic Substances)2836
Product category
Biomedical Research and Vaccine Production
Social media profiles2 records
Cost components4 values
Personnel, Technology or R&D, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Haffkine Institute conducts training, research, and testing on infectious diseases. It operates departments in Biochemistry and Biopharmaceuticals and has historically produced research cultures such as plague cultures used for microbiology and vaccine research purposes.

Differentiator
Functional benefit
Problem solved
Expansion highlight1 record

Each record includes

Type, Description

Peers10 records
1bioMérieux
TypeBroad incumbent
Description

Global leader in industrial and clinical microbiology diagnostics; broader incumbent in the same microbiology testing category as Haffkine, with significantly larger scale and global commercial reach.

2Bharat Biotech
TypeDirect peer
Description

Hyderabad-based vaccine and biotherapeutics developer; directly comparable to Haffkine's vaccine research and biopharmaceuticals mandate and competes for similar Indian and global public-health customers.

3Pasteur Institute
TypeDirect peer
Description

Historic French infectious disease research and vaccine institute; comparable in heritage-driven, multi-disciplinary infectious disease research, training, and public health reference lab mandate.

4National Institute of Virology (India)
TypeDirect peer
Description

Indian public-health virology reference laboratory under ICMR; directly comparable to Haffkine's infectious disease testing, research and reference lab mandate, with overlapping government and academic customer base in India.

5Indian Immunologicals Limited
TypeDirect peer
Description

India-based vaccine and biological products manufacturer operating across human and animal health; comparable to Haffkine's biopharmaceuticals and vaccine research scope and shares the Indian public-sector customer base.

6Thermo Fisher Scientific
TypeBroad incumbent
Description

Global life sciences tools and diagnostics conglomerate; broader incumbent that supplies the analytical instruments, reagents, and lab services ecosystem in which Haffkine operates.

7Hester Biosciences
TypeDirect peer
Description

India-based animal and human vaccine manufacturer; comparable to Haffkine in vaccine R&D and biopharmaceutical production, with overlapping infectious disease focus and Indian customer base.

8Serum Institute of India
TypeDirect peer
Description

World's largest vaccine manufacturer by doses; competes with Haffkine in the Indian vaccine and biologics space, and shares exposure to government immunization procurement and infectious disease programs.

9National Institute of Cholera and Enteric Diseases
TypeDirect peer
Description

Kolkata-based ICMR institute focused on enteric infectious disease research and reference testing; directly comparable in mission, public-sector funding model, and infectious disease testing/research activities.

10Hologic
TypeBroad incumbent
Description

Global diagnostics and women's health company with infectious disease testing offerings; broader incumbent in clinical infectious disease diagnostics with overlapping end customers (hospitals, public health labs).

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Haffkine Institute

Biomedical Research and Vaccine Productionhaffkineinstitute.org

Haffkine Institute firmographics

Firmographics
Name
Haffkine Institute
Website
https://haffkineinstitute.org
Company type
Private
Founded year
1899
Operating status
Operating
Headcount range
251–500 employees
Ownership category
akta.pro rank

Haffkine Institute industry classification

Industry
Product category
Biomedical Research and Vaccine Production
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Medical Laboratories (8071), Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731), Biological Products, (No Disgnostic Substances) (2836)
akta.pro primary industry
Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD)
akta.pro secondary industries
Disease-Specific Reference Laboratory Networks (e.g., TB, HIV, Influenza) (HLAJAIAD), Schools of Medical Laboratory Science & Clinical Diagnostics (EDAHAGAO), Microbiology & Infectious Disease Testing (Trial Support) (HLAGAEAF)

Keywords

  • Biomedical research
  • Vaccine production
  • Infectious disease testing
  • Microbiology research
  • Biopharmaceuticals

Where Haffkine Institute is headquartered

Location

Headquarters

HQ city
Parel
HQ country
India
HQ region
Asia

Offices1 record

Markets served

Haffkine Institute business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure

Haffkine Institute product offering

Product offering

Core offering

Haffkine Institute conducts training, research, and testing on infectious diseases. It operates departments in Biochemistry and Biopharmaceuticals and has historically produced research cultures such as plague cultures used for microbiology and vaccine research purposes.

Differentiator

Problem solved

Functional benefit

Companies that use Haffkine Institute

Customer profile

Segments1 record

Ideal customer profiles1 record

Haffkine Institute technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Haffkine Institute partnerships and signals

Strategic signal

Expansion highlights1 record

Haffkine Institute competitors and assessment

Company assessment

Broad incumbents

  • bioMérieux: Global leader in industrial and clinical microbiology diagnostics; broader incumbent in the same microbiology testing category as Haffkine, with significantly larger scale and global commercial reach.
  • Thermo Fisher Scientific: Global life sciences tools and diagnostics conglomerate; broader incumbent that supplies the analytical instruments, reagents, and lab services ecosystem in which Haffkine operates.
  • Hologic: Global diagnostics and women's health company with infectious disease testing offerings; broader incumbent in clinical infectious disease diagnostics with overlapping end customers (hospitals, public health labs).

Direct peers

  • Bharat Biotech: Hyderabad-based vaccine and biotherapeutics developer; directly comparable to Haffkine's vaccine research and biopharmaceuticals mandate and competes for similar Indian and global public-health customers.
  • Pasteur Institute: Historic French infectious disease research and vaccine institute; comparable in heritage-driven, multi-disciplinary infectious disease research, training, and public health reference lab mandate.
  • National Institute of Virology (India): Indian public-health virology reference laboratory under ICMR; directly comparable to Haffkine's infectious disease testing, research and reference lab mandate, with overlapping government and academic customer base in India.
  • Indian Immunologicals Limited: India-based vaccine and biological products manufacturer operating across human and animal health; comparable to Haffkine's biopharmaceuticals and vaccine research scope and shares the Indian public-sector customer base.
  • Hester Biosciences: India-based animal and human vaccine manufacturer; comparable to Haffkine in vaccine R&D and biopharmaceutical production, with overlapping infectious disease focus and Indian customer base.
  • Serum Institute of India: World's largest vaccine manufacturer by doses; competes with Haffkine in the Indian vaccine and biologics space, and shares exposure to government immunization procurement and infectious disease programs.
  • National Institute of Cholera and Enteric Diseases: Kolkata-based ICMR institute focused on enteric infectious disease research and reference testing; directly comparable in mission, public-sector funding model, and infectious disease testing/research activities.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights5 records

Customer concentration

Haffkine Institute social profiles

Digital presence

Haffkine Institute financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Haffkine Institute leadership team

Management profile

Number of profiles

Haffkine Institute funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Haffkine Institute M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Haffkine Institute

What does Haffkine Institute do?

Haffkine Institute conducts training, research, and testing on infectious diseases. It operates departments in Biochemistry and Biopharmaceuticals and has historically produced research cultures such as plague cultures used for microbiology and vaccine research purposes.

When was Haffkine Institute founded?

Haffkine Institute was founded in 1899. It employs 251 to 500 people.

Where is Haffkine Institute based?

Haffkine Institute is headquartered in Parel, India, in the Asia region.

Who are Haffkine Institute's main competitors?

Broad incumbents on record are bioMérieux, Thermo Fisher Scientific and Hologic. Direct peers are Bharat Biotech, Pasteur Institute, National Institute of Virology (India), Indian Immunologicals Limited, Hester Biosciences, Serum Institute of India and National Institute of Cholera and Enteric Diseases.

Does Haffkine Institute have an API?

No public API is recorded for Haffkine Institute.

What industry is Haffkine Institute in?

Haffkine Institute's product category is Biomedical Research and Vaccine Production. Its primary akta.pro industry code is HLAFAMAD, Microbiology & Infectious Disease Testing Laboratories, with a secondary code of HLAJAIAD, Disease-Specific Reference Laboratory Networks (e.g., TB, HIV, Influenza). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
TimesNowThe Pakur Estate Murder Case: The Inheritance Plot That Weaponised PlagueIn December 1933, Amarendra Chandra Pandey, joint heir to the Pakur Raj Estate in British India, died from bubonic plague after being injected with the bacterium at Howrah Station in Calcutta. Police investigation revealed the murder was orchestrated by his half-brother Benoyendra Chandra Pandey, who recruited research assistant Tara Nath Bhattacharya to obtain plague cultures from the Haffkine Institute in Bombay and carry out the killing to secure sole inheritance of the estate.BusinessLineImperilled Immunity — India’s ailing Vaccine PSUsAn investigative report details how India's oldest vaccine Public Sector Units — including Haffkine Institute, CRI-Kasauli and Pasteur Institute of India — have been suspended since 2008 for GMP non-compliance and now supply only 80% of UIP needs, down from 83%. Three PSUs signed a Bharat Biotech technology transfer agreement for Covid-19 vaccine production expected later this year.PR NewswireIcertis Contributes to Haffkine Institute in Support of the Fight Against COVID-19Icertis announced a contribution of INR 15 Lakhs to the Haffkine Institute in Pune to support clinical trials testing the Bacillus Calmette-Guérin (BCG) vaccine as a potential treatment for COVID-19, covering patient insurance, medical indemnities, drug supplies, and testing consumables. The Haffkine Institute is collaborating with the Maharashtra state government, government hospitals, and BJ Medical College to assess whether BCG can bolster COVID-19 patients' immune responses. The donation is part of Icertis' broader pandemic response, which has included over US$200,000 in contributions to global organizations including the University of Washington and the German Red Cross.PR NewswireIcertis Contributes to Haffkine Institute in Support of the Fight Against COVID-19Icertis donated INR 15 lakhs to Haffkine Institute to support testing the BCG vaccine as a COVID-19 treatment. The donation covers insurance, indemnity, drug supplies, and consumables for patient sample testing. The institute is collaborating with Pune's BJ Medical College and state hospitals.